Skip to main content
. 2023 Apr 3;14:1151780. doi: 10.3389/fimmu.2023.1151780

Table 1.

Characteristics of study participants.

PG
(N=11)
RG
(N=10)
NG
(N=10)
P-value
Age (years) 53 [44, 58] 54 [46.2, 59.2] 55 [44, 58.2] 0.953
Male Gender 8 (72.7%) 6 (60%) 6 (60%) 0.778
Months post-COVID infection 6 [4, 12] 5 [1.5, 9.5]* -- 0.515
Body Mass Index (kg/m2) 30.8 [24.3, 35.1] 26.9 [22.0, 34.6] No data 0.676
Received vaccination for COVID-19 9 (81.8%) 5 (50%) 8 (88.9%)* 0.116
Hospital admission (n, %)** 4 (36.3%) 0 0 0.015
Race
White/Caucasian 3 (27.3%) 1 (10%) 5 (50%) 0.160
Asian 4 (36.4%) 4 (40%) 5 (50%)
Native Hawaiian/Pacific Islander 3 (27.3%) 2 (20%) 0
Other 1 (9.0%) 3 (30%) 0
Co-morbidities
Asthma 1 (9.1%) 1 (10%) 1 (10%) 0.997
COPD 1 (9.1%) 0 0 0.391
Hypertension 3 (27.3%) 2 (20%) 1 (10%) 0.605
Diabetes 2 (18.2%) 1 (10%) 1 (10%) 0.809
Smoking history (past/current) 4 (36.4%) 2 (20%) 0 0.109
Current alcohol use 3 (27.3%) 5 (50%) 0 0.038

P-value calculated using Kruskal-Wallis test, Chi-square test, or Fisher’s exact test.

*1 missing data.

**One patient was admitted to the medical ICU for mechanical ventilatory support.

Bold indicates statistical significance.